Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.49 |
| ▸ | HTR6 | P50406 | 1/20 | 0.48 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.47 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | RBP4 | P02753 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30933718 | 0.93 | GPR119 (0.51) | GPR119HTR6BRD3KDM4EPKM | |
| SCHEMBL30933831 | 0.90 | GPR119 (0.49) | GPR119HTR6BRD3KDM4EPKM | |
| SCHEMBL30933782 | 0.89 | KDM4E (0.47) | GPR119HTR6KDM4EPKMSCN9A | |
| SCHEMBL23686979 | 0.85 | GPR119 (0.55) | GPR119BRD3KDM4EPKMTGFBR1 | |
| SCHEMBL30933731 | 0.85 | GPR119 (0.53) | GPR119HTR6BRD3KDM4EPKM | |
| SCHEMBL30933748 | 0.84 | GPR119 (0.50) | GPR119HTR6BRD3KDM4EPKM | |
| SCHEMBL30933771 | 0.83 | PKM (0.47) | GPR119HTR6KDM4EPKMSCN9A | |
| SCHEMBL30933793 | 0.81 | KDM4E (0.48) | GPR119HTR6KDM4EPKMTGFBR1 | |
| SCHEMBL30933735 | 0.80 | KDM4E (0.48) | HTR6KDM4EPKMSCN9ATGFBR1 | |
| SCHEMBL30933797 | 0.80 | KDM4E (0.48) | HTR6KDM4EPKMTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105007-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF | Samsara Therapeutics Inc. (US) | 2024-05-23 | — | — | WO | disclosed |